brentuximab,brentuximab,nivolumab,bendamustine
seagen,bms
['check,mate,744', 'lymphoma', 'hodgkin', 'checkmate 744']
with low-risk relapsed/refractory (r/r) classic hodgkin lymphoma (chl): checkmate 744. at #asco23 #ascodailynews #ayacsm #pedcsm 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.